Want to see MASS full AI Analyst Report?
MASS Stock Chart & Stats
$11.00
>-$0.01(-0.14%)
At close: 4:00 PM EDT
$11.00
>-$0.01(-0.14%)
Day’s Range― - ―
52-Week Range$5.03 - $12.93
Previous Close$7.13
Volume229.31K
Average Volume (3M)395.38K
Market Cap
$517.08M
Enterprise Value$229.69
Total Cash (Recent Filing)$101.53M
Total Debt (Recent Filing)$4.30M
Price to Earnings (P/E)―
Beta1.19
Next Earnings
Nov 16, 2026EPS Estimate
-0.16Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.93
Shares Outstanding41,333,706
10 Day Avg. Volume441,886
30 Day Avg. Volume395,383
Financial Highlights & Ratios
PEG Ratio0.10
Price to Book (P/B)1.32
Price to Sales (P/S)3.38
P/FCF Ratio-7.72
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price Target
$13.17Price Target Upside19.70% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)-0.86
Revenue Forecast (FY)$69.21M
Bulls Say, Bears Say
Bulls Say
Strong Revenue Growth And Upgraded GuidanceThe raised revenue outlook and strong Q2 growth indicate expanding demand for the company’s instruments and services. Sustained top-line growth can improve operating leverage, support continued product investment, and strengthen the installed base over the next several quarters.
Conservative Balance SheetA debt-free balance sheet with substantial liquidity provides flexibility to fund product development, acquisitions, and market expansion without near-term refinancing pressure. This financial capacity also gives the company greater resilience while it works toward sustained profitability.
Growing Platform Adoption And Recurring Revenue OpportunityNIRLAB expands the portfolio with an AI-powered, cloud-connected platform and introduces multiyear subscriptions to the installed base. Combined with existing consumables and services, this supports a larger recurring revenue mix and potentially more predictable customer economics.
Bears Say
Persistent UnprofitabilityDespite year-over-year improvement, the company remains substantially unprofitable, showing that revenue growth has not yet translated into durable earnings power. Continued losses can consume capital, limit self-funded investment, and leave results dependent on successful execution and margin improvement.
Product-mix Pressure On MarginsLower-margin products, discounted international orders, and changing service revenue mix could restrain gross-margin expansion even as sales grow. If these mix effects persist, they may delay breakeven and reduce the operating leverage expected from the company’s higher revenue base.
Recurring Revenue Growth Remains ModestRecurring revenue is an important stabilizing component of the business, but its modest growth shows that subscription and consumables monetization has not yet scaled rapidly. Reaching management’s targeted higher recurring mix will require sustained customer utilization and successful subscription adoption.
908 Devices News
MASS FAQ
What was 908 Devices’s price range in the past 12 months?
908 Devices lowest stock price was $5.03 and its highest was $12.93 in the past 12 months.
What is 908 Devices’s market cap?
908 Devices’s market cap is $517.08M.
When is 908 Devices’s upcoming earnings report date?
908 Devices’s upcoming earnings report date is Nov 16, 2026 which is in 44 days.
How were 908 Devices’s earnings last quarter?
908 Devices released its earnings results on Aug 11, 2026. The company reported -$0.32 earnings per share for the quarter, missing the consensus estimate of -$0.142 by -$0.178.
Is 908 Devices overvalued?
According to Wall Street analysts 908 Devices’s price is currently Undervalued.
Does 908 Devices pay dividends?
908 Devices does not currently pay dividends.
What is 908 Devices’s EPS estimate?
908 Devices’s EPS estimate is -0.16.
How many shares outstanding does 908 Devices have?
908 Devices has 41,333,706 shares outstanding.
What happened to 908 Devices’s price movement after its last earnings report?
908 Devices reported an EPS of -$0.32 in its last earnings report, missing expectations of -$0.142. Following the earnings report the stock price went up 13.75%.
Which hedge fund is a major shareholder of 908 Devices?
Currently, no hedge funds are holding shares in MASS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
908 Devices Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$13.17 (19.70% Upside)
$13.17 (19.70% Upside)
Blogger Sentiment
Bullish
MASS Sentiment 75%
Sector Average 65%
Sector Average 65%
Hedge Fund Trend
Increased
By 208.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.4M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.7%
Last 30 Days ▲ 23.8%
Last 30 Days ▲ 23.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
45.02%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
3.04%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
908 Devices
908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company’s products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable FTIR device that rapidly detects and identifies approximately 28,000 unknown gas, vapor, powder, and liquid chemical hazards; ProtectIR, a handheld FTIR device that can identify approximately 23,000 solid and liquid chemical hazards; and VipIR, a handheld 3-in-1 analyzer that integrates FTIR, Raman spectroscopy, and smart spectral processing (SSP), a proprietary algorithm, to provide a single result from just one sample. It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas. The company was incorporated in 2012 and is headquartered in Burlington, Massachusetts.
MASS Company Deck
MASS Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presents a constructive operational and commercial narrative with strong top-line growth (Q2 revenue +23%), clear product momentum across FTIR, MX908 and XplorIR, meaningful large orders and an accretive strategic acquisition (NIRLAB) showing early subscription traction. Profitability metrics are improving materially (adjusted EBITDA loss cut by ~50%, adjusted gross margin up ~85 bps) and the balance sheet is healthy with $101.5M in cash and no debt. Offsetting these positives are continuing GAAP losses, remaining negative adjusted EBITDA, margin pressure from some newer/lower-margin product volumes and uncertainty around the timing/path of the AVCAD defense opportunity (excluded from guidance). Overall, the positives — durable revenue growth, improving margins, strong device momentum and early recurring revenue from NIRLAB — outweigh the challenges, though execution risk on margins, recurring revenue scale and the AVCAD outcome remain items to monitor.View all MASS earnings summariesMASS Stock 12 Month Forecast
Average Price Target
$13.17
▲(19.70% Upside)
Technical Analysis
Senseonics Holdings
―
Quanterix
―
Nano-X Imaging
―
TriSalus Life Sciences
―
Cytek Biosciences
―
Ownership Overview
32.82% Insiders
11.57% Mutual Funds
7.39% Other Institutional Investors
34.36% Public Companies and
Individual Investors